# Study to Investigate the Effect of AB-101 in Breast Cancer Survivors

> **NCT03592121** · EARLY_PHASE1 · COMPLETED · sponsor: **Applied Biology, Inc.** · enrollment: 3 (actual)

## Conditions studied

- Sexual Dysfunction
- Sexual Arousal Disorder
- Sexual Dysfunction, Physiological
- Breast Cancer
- Nipple Disorder
- Neuropathy
- Cancer of Breast

## Interventions

- **DRUG:** AB-101
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03592121
- **Lead sponsor:** Applied Biology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-09
- **Primary completion:** 2019-10-12
- **Final completion:** 2019-10-12
- **Target enrollment:** 3 (ACTUAL)
- **Last updated:** 2020-03-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03592121

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03592121, "Study to Investigate the Effect of AB-101 in Breast Cancer Survivors". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT03592121. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*